Projeto
Rab proteins as novel biomarkers in breast cancer
| Referência: | PD/BD/128339/2017 |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Nova de Lisboa |
Registos relacionados
Breast cancer chemotherapy: sympathetic overexcitation as an earlier complementary biomarker of cardiotoxicity
Intracellular traficking and acute kidney injury: Rab GTPase as markers of tubular lesion.
Cellulose bio-nanocomposites as test-strips for protein cancer biomarkers
High-performance magnetic nanoparticle-based immunoassays for breast cancer biomarker analysis
GENETIC SUSCEPTIBILITY TO BREAST CANCER
Non-invasive, innovative and promising strategy for early diagnosis of breast cancer through the establishment of urinary volatile metabolomic profiles of breast cancer patients as well as from breast cancer tissues and breast cancer cell lines
The blood-brain barrier in brain metastasization of breast cancer: a source of biomarkers, a target for modulation and an obstacle to overcome
TRESPASS2TREAT: A novel approach in pharmacotherapies for breast cancer patients with brain metastasis.
Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment
Development of novel multifunctional nano-polyplexes as imaging and delivery vectors against triple negative breast cancer
Design of novel breast tumor ‘targeted` multifunctional nanoparticles
Exosomes as drug delivery systems in metastatic breast cancer
Role of E-selectin ligands in breast cancer metastasis
Test-strips for monitoring cancer biomarkers in point-of-care
Effects of Combined vs. Resistance Training on Quality of Life and other Cancer-Related Biomarkers: a 4-month Randomized Control Trial conducted on Breast Cancer Patients Undergoing Chemotherapy
MODULATION OF BASE EXCISION REPAIR PATHWAY FOR BREAST CANCER THERAPY
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
Tracking early Cardiotoxicity developed during Chemotherapy in breast Cancer
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Smart hydrogel-based Injectable systems for breast cancer theranostics
Phospholipase C epsilon as a Biomarker of Colorectal Cancer Progression
SERS-based biosensors for on-site determination of pancreatic cancer biomarkers
SERS-based biosensors for on-site determination of pancreatic cancer biomarkers
Phospholipase C epsilon as a Biomarker of Colorectal Cancer Progression
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
Search for candidate protein biomarkers of Coffea arabica resistance to Hemileia vastatrix (leaf rust)
Nano-electrode arrays Biosensor for Early and Decentralized Breast-Cancer Diagnosis
A new vision for fuel cells: application in cancer biomarker screening
Relative effectivity of aromatase inhibitors versus tamoxifen in patients with early breast cancer
Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Construction of point-of-care molecularly imprinted electrochemical devices for cancer biomarkers detection
Exploring the antitumor effect of HLA-DR+ Cytotoxic T Lymphocytes in prognosis and treatment of Breast Cancer
The role of long non-coding RNAs on the molecular circuitry and metabolic adaptation of breast cancer.
Axillary Lymph Node Microwave Imaging ALN-MWI to Improve Breast Cancer Diagnosis
Exploring the antitumor effect of HLA-DR+ Cytotoxic T Lymphocytes in prognosis and treatment of Breast Cancer
Cracking glycan-lectin interactions to target immunosuppressive macrophages in triple-negative breast cancer
Design, synthesis and biological evaluation of novel p53 activators by targeting p53 protein-protein interactions
Bolsa de Doutoramento FCT: Genetic Polymorphisms of NRF2-KEAP1 and Protein Expression in Breast Cancer: a marker for prognosis and treatment [SFRH/BD/146395/2019]
Publicações relacionadas
Carregando publicações...